HIV & AIDS

HIV therapies provide near normal lifespan in Africa

A landmark study by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia (UBC) shows that patients in Africa receiving combination antiretroviral therapy (cART) for HIV can expect to live ...

HIV & AIDS

New drug adds to arsenal against AIDS

A new drug, rilpivirine, can add powerfully to the combination of medications used to control HIV for first-time patients, researchers conclude in Friday's issue of The Lancet.

HIV & AIDS

1 in 4 new HIV infections in Ontario are among women: study

Despite significant clinical advances in HIV care, an estimated 25 per cent of new HIV infections in Ontario from 2006 to 2008 were among women, according to a health study by researchers from the Institute for Clinical Evaluative ...

page 30 from 31